SOURCE: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc.

May 02, 2011 09:00 ET

James P. Boyd, D.D.S. to Unveil New Product Line at Large Dental Conference

SAN DIEGO, CA--(Marketwire - May 2, 2011) - Therapeutic Solutions International, Inc. (OTCQB: TSOI) (PINKSHEETS: TSOI), the only manufacturer of the chairside NTI Tension Suppression System that has helped countless patients prevent debilitating migraine and tension headache pain, announced today that James P. Boyd, D.D.S., Director of Research and Product Development at Therapeutic Solutions International ("TSI") will present at this year's "Dentaltown" meeting to be held May 4-7 in Las Vegas, Nevada.

The annual "Townie Meeting" conference brings together dental professionals from around the world and provides a forum for sharing information and discussing the enabling technologies that are driving today's dental profession.

Not only will Dr. Boyd's presentation focus on the NTI Tension Suppression System ("NTI") (Dr. Boyd is the inventor of the NTI and is credited with establishing an entire new market of drug-free migraine prevention), he will introduce the "Total Splint Solution," a companion product line to the NTI.

"Although the NTI serves a market that is in desperate need of pain prevention, there is an even larger population of patients whose condition dictates a treatment more focused on dental protection than migraine prevention," stated Dr. Boyd.

"Due to its ease and simplicity of use, dental practitioners have often employed the NTI for conditions that it was not originally intended for," said Tim Dixon, TSI's president. "With the introduction of the Total Splint Solution, which consists of NTI matrices, as well as the components of our Total Splint System, TSI can now provide a wide of variety of therapeutic and protective modalities that can fit any dentist's needs."

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc. is a company whose business plan is focused on the development, production and marketing of cost effective technologies and therapeutic modalities for the treatment and prevention of common neurologic, sleep and temporomandibular disorders. TSI has several important websites to disseminate information and market their products. Our clinical research site for the NTI is www.nti-tss.com and our e-commerce portal is located at www.ordertsi.com. Our patient education site located at www.headacheprevention.com, and our corporate website for TSI is www.therapeuticsolutionsint.com.

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, termination of contracts or agreements, technological obsolescence of our products, technical problems with our research and products, price increases for supplies and components, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at www.sec.gov.

Contact Information